Vanadis Diagnostics | GenomeWeb

Vanadis Diagnostics

The company said selling this business unit frees it to focus on developing new maternal and fetal health solutions for the US and elsewhere.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.